breast neoplasms
Showing NaN - NaN of 36
Breast Tumors Trial in Israel, Korea, Republic of, United States (Atezolizumab (MPDL3280A), an engineered anti-programmed
Active, not recruiting
- Breast Neoplasms
- Atezolizumab (MPDL3280A), an engineered anti-programmed death-ligand 1 (PD-L1) antibody
- +7 more
-
Birmingham, Alabama
- +26 more
Dec 21, 2022
Breast Tumors Trial in United States (endocrine therapy alone without radiotherapy)
Active, not recruiting
- Breast Neoplasms
- endocrine therapy alone without radiotherapy
-
Stanford, California
- +12 more
Dec 20, 2022
Breast Tumors Trial in Worldwide (PD-0332991, Letrozole, Placebo)
Active, not recruiting
- Breast Neoplasms
- PD-0332991
- +2 more
-
Bellflower, California
- +304 more
Dec 6, 2022
Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG
Recruiting
- Breast Neoplasms
- +10 more
- Standard Therapy
- +32 more
-
Birmingham, Alabama
- +35 more
Nov 17, 2022
Breast Tumors Trial in Worldwide (Abemaciclib, Fulvestrant, Placebo)
Active, not recruiting
- Breast Neoplasms
- Abemaciclib
- +2 more
-
Fayetteville, Arkansas
- +141 more
Nov 15, 2022
Breast Tumors, Tumor Metastasis Trial in Worldwide (Imlunestrant, Exemestane, Fulvestrant)
Recruiting
- Breast Neoplasms
- Neoplasm Metastasis
- Imlunestrant
- +3 more
-
Chandler, Arizona
- +238 more
Aug 17, 2022
Among Talazoparib-Treated HER2-Negative mBC With gBRCA1/2m
Completed
- Metastatic Breast Cancer
- Breast Neoplasms
-
New York, New YorkPfizer Inc.
Aug 5, 2022
MRI Scans in People Who Have Breast Tissue Expanders After
Recruiting
- Breast Cancer
- +2 more
- MRI Studies
- Patient Reported Outcomes
-
Montvale, New Jersey
- +2 more
May 31, 2022
Breast Tumors, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation Trial in Worldwide (talazoparib, Physician's-Choice)
Completed
- Breast Neoplasms
- +2 more
-
Flagstaff, Arizona
- +361 more
Dec 20, 2021
Breast Tumors, Early Detection of Cancer Trial in New York, Durham, Memphis (Patient activation, Primary care physician
Active, not recruiting
- Breast Neoplasms
- Early Detection of Cancer
- Patient activation
- +2 more
-
New York, New York
- +4 more
Sep 17, 2021
Breast Tumors, Breast Diseases Trial in New York (Anastrozole, Palbociclib, Trastuzumab)
Recruiting
- Breast Neoplasms
- Breast Diseases
- Anastrozole
- +3 more
-
New York, New York
- +4 more
Jun 25, 2021
Breast Tumors, Musculoskeletal Pain Trial in New York (Hypnosis, Attention Control)
Completed
- Breast Neoplasms
- Musculoskeletal Pain
- Hypnosis
- Attention Control
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Jun 15, 2021
Ascertainment of Peripheral Blood or Saliva Samples for Genetic
Active, not recruiting
- Breast Neoplasms
- +6 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jun 14, 2021
Breast Tumors Trial in New York (RealRisks, BNAV)
Completed
- Breast Neoplasms
- RealRisks
- BNAV
-
New York, New YorkColumbia University Medical Center
Jan 7, 2021
Breast Tumors, Tumor Metastasis Trial in Puerto Rico, United States (ABI-007 (Abraxane), bevacizumab)
Terminated
- Breast Neoplasms
- Neoplasm Metastasis
- ABI-007 (Abraxane)
- bevacizumab
-
Birmingham, Alabama
- +39 more
Nov 7, 2019
Breast Tumors, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation Trial in Worldwide (talazoparib)
Terminated
- Breast Neoplasms
- +2 more
-
Greenbrae, California
- +70 more
Oct 10, 2019
Breast Cancer, Breast Tumors, Breast Tumors Trial in Belgium, France, United States (AMG 386 30 mg/kg, Paclitaxel and
Completed
- Breast Cancer
- +9 more
- AMG 386 30 mg/kg, Paclitaxel and Trastuzumab
- +3 more
-
Tucson, Arizona
- +22 more
Apr 2, 2019
Advanced Breast Cancer, Advanced Malignant Solid Tumors, Breast Tumors Trial in Worldwide (HKI-272, Paclitaxel)
Completed
- Advanced Breast Cancer
- +2 more
-
La Jolla, California
- +31 more
Jun 27, 2018
Breast Cancer, Breast Tumors Trial in Spain, United States (XL147 (SAR245408), trastuzumab, paclitaxel)
Completed
- Breast Cancer
- Breast Neoplasms
- XL147 (SAR245408)
- +2 more
-
Los Angeles, California
- +8 more
May 9, 2016
Breast Cancer, Breast Tumors Trial in New York (Imiquimod)
Completed
- Breast Cancer
- Breast Neoplasms
-
New York, New YorkNYU Cancer Institute
Nov 6, 2015